The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: cisplatin
Drug: everolimus
Drug: paclitaxel
Other: placebo
Procedure: Venous blood draw

First Posted Date: 2009-07-02

Last Posted Date: 2015-05-07

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 145

Registration Number: NCT00930930

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸
The Methodist Hospital Research Institute, Houston, Texas, United States

and more 5 locations

Studying Biomarkers in Patients With Pancreatic Cancer

Completed

Conditions: Pancreatic Cancer

Interventions: Genetic: protein analysis
Other: laboratory biomarker analysis

First Posted Date: 2009-05-12

Last Posted Date: 2013-12-12

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 53

Registration Number: NCT00900003

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202

Completed

Conditions: Solid Tumor
Lymphoma

First Posted Date: 2009-05-12

Last Posted Date: 2016-04-25

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 9

Registration Number: NCT00896662

Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer

Completed

Conditions: Ovarian Cancer

Interventions: Genetic: protein expression analysis
Other: immunohistochemistry

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-18

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 7

Registration Number: NCT00900523

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Completed

Conditions: Breast Cancer
Head and Neck Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer

Interventions: Procedure: venipuncture
Radiation: radiation therapy

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-12

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 25

Registration Number: NCT00897793

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer

Withdrawn

Conditions: Liver Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-10

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Registration Number: NCT00899002

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Terminated

Conditions: Head and Neck Cancer

Interventions: Genetic: DNA Microarray analysis
Genetic: MALDI-TOF mass spectrometry
Genetic: DNA microarray and MALDI-TOF mass spectrometry

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 49

Registration Number: NCT00898430

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Immunoreactivity to Cetuximab in Cancer Patients

Completed

Conditions: Colorectal Cancer
Head and Neck Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 538

Registration Number: NCT00896896

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 54

Registration Number: NCT00899340

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Completed

Conditions: Head and Neck Cancer

Interventions: Other: proteomic profiles

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-02

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 352

Registration Number: NCT00896675

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy